A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults
A Phase 1a Randomized, Double-blind, Placebo-controlled, Single Site, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Kindolor Tosylate in Healthy Adults
Sponsor: Lohocla Research Corporation
Terminated
Terminated by sponsor due to low drug bioavailability; no safety concerns were noted.
Other Chronic Pain trials with similar outcome
A PHASE1 clinical study on Chronic Pain, this trial is terminated or withdrawn. The trial is conducted by Lohocla Research Corporation and has accumulated 7 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Nov 2025 — Present [monthly]
Terminated PHASE1
Status: Active Not Recruiting → Terminated
-
Feb 2025 — Nov 2025 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE1
▶ Show 2 earlier versions
-
May 2024 — Jul 2024 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Mar 2024 — May 2024 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Lohocla Research Corporation
- National Institute on Drug Abuse (NIDA)
For direct contact, visit the study record on ClinicalTrials.gov .